The alfapump® system is not currently approved in the United States or Canada. In the United States and Canada, the alfapump® system is currently under clinical investigation (POSEIDON Study) and is being studied in adult patients with refractory or recurrent ascites due to cirrhosis. For more information regarding the POSEIDON clinical study see www.poseidonstudy.com.
The DSR therapy is still in development and it should be noted that any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed.
The DSR therapy is not currently approved for clinical research in the United States or Canada. There is no link between the DSR therapy and ongoing investigations with the alfapump® system in Europe.

alfapump® implantation video

Please contact your Sequana Medical representative prior to scheduling an alfapump® system implantation.

By providing your email, you confirmed that you are a physician and understand that the implantation video is only provided as general information and does not replace the information provided in the instruction for the use and the required training to carry out an alfapump® system implantation provided by Sequana Medical clinical specialists.

Please enter your email to request the link leading to the alfapump® implantation video.


    We remind you that the video contains images that may hurt your sensitivity.